Explore the latest in dyslipidemia, including recent guidelines for screening and use of statins, PCSK9 inhibitors, and other treatments.
This cohort study examines the association between Mediterranean diet intake and cardiovascular risks and attempts to identify which biological mechanisms underlie the association among participants of the Women’s Health Study.
This cohort study evaluates the association of adherence and treatment intensity with cardiovascular outcomes in patients with documented cardiovascular disease, type 2 diabetes without cardiovascular disease or chronic kidney disease, and chronic kidney disease without cardiovascular disease.
This randomized clinical trial examines whether 6 months of daily docosahexaenoic acid supplementation during the second year of life improves developmental outcomes of children who were born preterm.
This secondary analysis of the ASTRONOMER randomized clinical trial assesses whether plasma levels of lipoprotein(a) have a linear or a threshold association with rate of progression among patients with calcific aorta valve stenosis.
This randomized survey study explores how communication tools and presentation formats influence the perception of the severity of atherosclerotic cardiovascular disease risk as well as the potential willingness to take medication therapy among patients in the Patient and Provider Assessment of Lipid Management Registry.
This cohort study uses UK Whitehall II study data to characterize changes in cardiovascular risk factors over 10 years and associations between change in risk and incident cardiovascular events among people without baseline cardiovascular disease.
This cross-sectional study uses National Health and Nutrition Survey data to model a 10-year risk, 10-year benefit, and 30-year benefit approach to selecting individuals for statin therapy.
This case series study examines the association between APOA5 and APOC3 polymorphisms and triglyceride levels in patients with cutaneous T-cell lymphoma before, during, and after treatment with bexarotene.
This cohort study compares whether the continuation vs discontinuation of statins from advanced chronic kidney disease into the dialysis therapy period is associated with improved all-cause mortality and cardiovascular mortality in US veterans.
This genetic association study investigates the independent and combined associations of genetically determined differences in lipoprotein lipase–mediated lipolysis and low-density lipoprotein cholesterol metabolism with risk of coronary disease and diabetes.
This model-based economic evaluation examines the cost-effectiveness of financial incentives for patients and physicians in controlling low-density lipoprotein (LDL) cholesterol levels.
This cohort study evaluates the association between lichen planopilaris, hyperlipidemia, and metabolic syndrome.
This study evaluates the pooled cohort equation’s accuracy for predicting 10-year risk of atherosclerotic cardiovascular disease among participants in the Women’s Health Initiative.
This meta-analysis evaluates efficacy and safety of further lowering low-density lipoprotein cholesterol levels in patient populations presenting with median low-density lipoprotein cholesterol levels of 70 mg/dL or less.
This cluster randomized clinical trial evaluates the effect of a remotely delivered multicomponent behaviorally tailored intervention vs usual care on adherence to medications for hyperlipidemia, hypertension, and diabetes in patients who are nonadherent to prescribed medications.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: